Ask a Patient® Health News: Drugs & Treatments

Ask a Patient® Health News: Drugs & Treatments

Home
Notes
Drug Safety Updates
Special Features
About

Sitemap - 2025 - Ask a Patient® Health News: Drugs & Treatments

Caplyta (lumateperone) Capsules: How a New Approval Can Change a Drug Label in Unexpected Ways

November Drug Safety Part 2: Huge Duloxetine and Zyban generic recall; Bupropion-containing meds; Caplyta for major depression; TMS device approved; Hypothyroid treatments

November 2025 Drug Safety: Recalls for Compounded Semaglutide, Generic Synthroid; Safety Updates for Lamictal, Kineret, Miebo Eye Drops, Zoladex; Microneedling Injuries, more

Unique Glasses for Kids; Drugs for Common Diseases Get Fast-Tracked; Cancer and Pain Treatment Research; Gabapentin Update; Flu Season News, Protein Supplements Tips; Bankrupt Rite Aid Sues CVS

Huge recall of Glaucoma and Allergy Eye Drops, Recall of Granules' Generic Adderall XR; Acetaminophen Safety; Semaglutide and Serious Eye Condition Warning; Recommended Videos and Podcast

Note to Readers - Newsletter to be sent October 6

Nationwide Recalls for Cyclobenzaprine, Multiple Generics; Warnings for Briviact, Lupron Depot, Riluzole, Tepezza, Tiglutek; Pharma Ad Crackdown, More

World’s Essential Medicines: What did and didn't make the list; Medical device sterilization dilemma; Eye drops for nearsightedness, Meds for liver, lung disease, fibromyalgia; ❤️for beet juice

FDA To Tighten Regulation of Natural Thyroid Medications

August 2025 Safety Update Part 2: Liver Injury and MS Drugs; Xyzal Warning; Recalls for Metoprolol, Spironolactone, Compounded GLP-1s; Supplements and Vitamins Tips

August 2025 Drug Safety: Huge Recall of Glaucoma Eye Drops; Duloxetine and Other Generic Recalls; HRT Comments; Opioid and Kratom 7-OH Warnings

August 10, 2025: New Drug Approvals for Brain, Lung cancer; Migraine Treatment for Kids; AI therapy banned in IL; Alzheimer's Link to Lithium Levels

July 2025 Safety Update: New drug for hand eczema, heart failure; warnings for testosterone meds, Opdivo; FDA halts Elevidys gene therapy; green tea drug interactions; anemia in older patients

Special Update on Alzheimer’s Drugs Leqembi (lecanemab) and Kisunla (donanemab)

Expanded Approvals for Dupixent, Keytruda, Mavyret, Nucala, Susvimo; New Meds: Widaplik for High Blood Pressure, Yeztugo for HIV prevention

June 2025 Safety Update Part 2: Warnings for Transderm Scop, Caprelsa, Hyzaar, Xarelto, GLP-1s (Mounjaro and more)

June 2025 Drug Safety Update: Recalls of Carvedilol, Zicam Nasal Swabs, Generic Bactrim; New Warnings for Depakote and Lamictal; GLP-1 meds and Eye Disease (wet AMD)

Nationwide eye drops recall; New lung, liver, ovarian cancer drugs; Gene therapy trial tragedy; new migraine injectable; Allergy med tips; Fish oil supplement good news; more

May 2025 Safety Update Part 2: Spravato Antidepressant, Clozapine, Ambrisentan, Korean Sunscreens, Children's Claritin, "Gas Station Heroin," Fluoride Tablets, Medication Tips

May 2025 Safety Update: Duloxetine Recall; New Warnings for Gabapentin, Lyrica, Doxycycline, Other Antibiotics; Animal Testing Changes; FDA Delays Continue; Medication Tips

Phase-out of Animal Studies Requirement for Investigational New Drug Applications

FDA Delays Some Updates; Product Warnings for Topical Hair Loss Treatment; Supplements with Hidden Ingredients; Counterfeit Ozempic

April 2025 Drug Safety: Lidocaine cream; new side effects for migraine drugs; antidepressants study; Pluvicto for prostate cancer; Imfinzi; Tymlos; vitamin B-12 quality; microplastics in teabags

March 2025 Drug Safety Part 2: New warnings for MRI contrast agents; Baqsimi, Belsomra, Furoscix, Iluvien ophthalmic, Metronidazole; Recalls of ADHD and acne meds; medication tips

March 2025 Drug Safety Updates Part 1: Cardiac Risk Warning Removed for Testosterone Meds; News for Bactrim, Lybalvi, Nplate, Prolensa, Remicade, TNKase

Drug and Device Approvals: Deep Brain Stimulation Therapy for PD; generic Xarelto; neffy nasal epinephrine spray; Odactra for dust mite allergies; Encelto for rare eye disease

February 2025 Part 3 Drug Safety News: Geodon; Paxlovid; Ozempic shortage ends; blood thinners and A-Fib; drug-induced high blood pressure; REMS news; podcast recommendation

February 2025 Drug Safety Part 2: FDA REMS news; Abilify; Isoniazid; Ongentys for Parkinson's; Osphena for menopause

February 2025 Drug Safety Updates Part 1: Enhertu, Omvoh, Ozempic expanded approvals and new warnings; MS drug's new boxed warning; glaucoma eye drops and corneal swelling; Xtandi choking risk; more

New Formulations for Popular Meds; Nicotine and Health Risks; Generic Facility Warned; Anti-Aging Emerging Therapies and Hype; More

January 2025 Part 1: Safety warning for RSV vaccines; Depo Provera contraceptive link to brain tumors; iron infusion therapy risk; Ozempic and rare eye condition; Gemtesa for overactive bladder; more

© 2025 AskaPatient.com
Start your SubstackGet the app
Substack is the home for great culture